• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Q2 Supply chain, COVID-19 issues lead to slightly lowered expectations for GE HealthCare

Q2 Supply chain, COVID-19 issues lead to slightly lowered expectations for GE HealthCare

July 26, 2022 By Sean Whooley

GE HealthCare's new logo
The new logo for the stand-alone GE HealthCare company, expected to spin off early next year. [Image courtesy of GE Healthcare]
GE (NYSE:GE) shares were up on second-quarter results that came in ahead of the consensus forecast on Wall Street — though there are reduced expectations for the HealthCare business.

The Boston-based company posted losses of $1.2 billion, or 78¢ per share, on sales of $18.6 billion for the three months ended June 30, 2022, for a large bottom-line slide into the red on sales growth of 2.2%.

Adjusted to exclude one-time items, earnings per share were 78¢, 40¢ ahead of Wall Street, where analysts were looking for sales of $17.6 billion.

Despite The Street’s reaction to the company-wide performance, driven by GE’s aerospace segment, the company’s HealthCare arm suffered in the second quarter.

GE HealthCare registered revenues of $4.5 billion, marking a 1.5% uptick year-over-year from 2021. Profits came in at $651 million for an 18.7% bottom-line slide from the same quarter last year.

The company said in a news release that COVID-19’s impact in China and continued supply chain challenges were the driving force behind the business’ performance. Growth was driven by the company’s imaging, ultrasound and healthcare systems services.

Due largely to inflation pressure, GE expects HealthCare profit to be approximately $3 billion in 2022, slightly below the company’s prior outlook. GE expects mid-single-digit revenue growth versus prior guidance of low-to-mid-single digit growth in 2022 in HealthCare.

“We’re building meaningfully stronger businesses as we focus on serving our customers and investing through these constraints,” GE Chair and CEO H. Lawrence Culp said in the release. “We are on track and confident in our plans to form three independent companies positioned to create long-term value.”

GE HealthCare remains on track to spin off as its own company. It will trade under the symbol GEHC on the Nasdaq after the planned completion of the spinoff, scheduled for early 2023.

GE projects company-wide metrics to trend toward the low end of its 2022 outlook, except on free cash flow. Working capital will be pressured as the company looks to protect customers from the impact of supply chain challenges.

Shares of GE were up 5.4% at $72.01 in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was virtually unchanged.

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: GE Healthcare

More recent news

  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure
  • NanoVibronix enters into $50M financing agreement

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy